EBR Systems, which develops cardiac pacing devices, has raised a $35 million third round of financing. This money will help it take its product to clinical trials, according to VentureWire.

Delphi Ventures led this round, with existing investors De Novo Ventures, Frazier Healthcare Ventures, Split Rock Partners and SV Life Sciences joining in.

The Sunnyvale, Calif-based EBR has raised $27 million in its previous two rounds.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Discover our Briefings.